M. Nishimura et al., CARDIOVASCULAR REGULATION BY L-ARGININE IN THE BRAIN OF RATS - ROLE OF THE BRAIN RENIN-ANGIOTENSIN SYSTEM AND NITRIC-OXIDE, American journal of hypertension, 10(4), 1997, pp. 389-396
The effect of brain L-arginine on arterial pressure was investigated b
y injecting L- or D-arginine into the cerebral ventricles of male Wist
ar rats that were anesthetized with urethane. Intracerebroventricular
(ICV) injection of 1 mu mol L-arginine reduced the arterial pressure a
nd the abdominal sympathetic nervous activity (SNA), whereas the injec
tion of 10 mu mol L-arginine induced a transient presser response and
reduced both the heart rate and SNA. Although ICV injection of 1 mu mo
l D-arginine had no effect on cardiovascular function or SNA, injectio
n of 10 mu mol of this enantiomer elicited a transient presser respons
e, similar to that induced by 10 mu mol L-arginine, followed by a pers
istent increase in arterial pressure and a corresponding increase in S
NA. ICV pretreatment with the nitric oxide synthase inhibitor N-G-mono
methyl L-arginine abolished the vasodepressor response and reduced the
inhibition of SNA induced by ICV injection of 1 mu mol L-arginine; su
ch pretreatment increased the arterial pressure, heart rate, and SNA m
easured 30 min after ICV injection of 10 mu mol L-arginine. ICV pretre
atment with the angiotensin II type 1 receptor antagonist CV-11974 inh
ibited the presser response to 10 mu mol L-arginine and the first phas
e of the presser response to 10 mu mol D-arginine. Intravenous pretrea
tment with the alpha(1)-adrenoceptor blocker bunazosin hydrochloride a
bolished the presser response to 10 mu mol L-arginine and both phases
of the presser response to 10 mu mol D-arginine. Brain L-arginine thus
appears to exert presser actions through stimulation of the brain ren
in-angiotensin system and peripheral SNA. However, these actions may b
e attenuated by L-arginine-derived nitric oxide. (C) 1997 American Jou
rnal of Hypertension, Ltd.